SCHEMBL20735804

SCHEMBL20735804

c1ccc(-c2ccc(-c3ccc4cc5c(cc4c3)C3(c4ccccc4-c4ccccc43)c3c-5c4ccccc4c4ccccc34)cc2)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 4/20 0.41
ABL1 P00519 3/20 0.35
DHODH Q02127 1/20 0.34
KDM4E B2RXH2 3/20 0.33
TP53 P04637 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HSD17B10 Q99714 3/20 0.33
LMNA P02545 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
TSHR P16473 2/20 0.33
PKM P14618 1/20 0.33
KLF5 Q13887 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAPK1 P28482 3/20 0.33
CCR1 P32246 2/20 0.33
CCR5 P51681 2/20 0.33
CCR8 P51685 2/20 0.33
ALPL P05186 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20735871 0.96 PDK2 (0.38) PDK2ABL1DHODHKDM4ETP53
SCHEMBL20735862 0.92 PDK2 (0.38) PDK2ABL1KDM4ETP53SMN1; SMN2
SCHEMBL20735869 0.92 PDK2 (0.41) PDK2ABL1DHODHKDM4ETP53
SCHEMBL20735863 0.91 PDK2 (0.39) PDK2ABL1KDM4ETP53SMN1; SMN2
SCHEMBL20735861 0.91 PDK2 (0.37) PDK2ABL1KDM4ETP53SMN1; SMN2
SCHEMBL20735864 0.90 PDK2 (0.38) PDK2ABL1KDM4ETP53SMN1; SMN2
SCHEMBL20735801 0.87 PDK2 (0.35) PDK2NPC1
SCHEMBL20735872 0.87 PDK2 (0.31) PDK2KDM4ETP53SMN1; SMN2LMNA
SCHEMBL20735802 0.87 PDK2 (0.43) PDK2KDM4ESMN1; SMN2HSD17B10LMNA
SCHEMBL20735803 0.86 PDK2 (0.36) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDK2 2420/4885ABL1 1400/4885DHODH 3510/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 PDK2 2420/4885ABL1 1400/4885DHODH 3510/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDK2 2420/4885ABL1 1400/4885DHODH 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.